To include your compound in the COVID-19 Resource Center, submit it here.

RSD1235: Phase III data

In the placebo-controlled, U.S., Canadian and Scandinavian Phase III ACT 1 trial in 420 patients, RSD1235

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE